Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Other Non-Current Assets: 2011-2024

Historic Other Non-Current Assets for Niagen Bioscience (NAGE) over the last 11 years, with Dec 2024 value amounting to $368,000.

  • Niagen Bioscience's Other Non-Current Assets rose 174.34% to $417,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $417,000, marking a year-over-year increase of 174.34%. This contributed to the annual value of $368,000 for FY2024, which is 142.11% up from last year.
  • Niagen Bioscience's Other Non-Current Assets amounted to $368,000 in FY2024, which was up 142.11% from $152,000 recorded in FY2023.
  • Niagen Bioscience's 5-year Other Non-Current Assets high stood at $368,000 for FY2024, and its period low was $152,000 during FY2021.
  • Over the past 3 years, Niagen Bioscience's median Other Non-Current Assets value was $152,000 (recorded in 2023), while the average stood at $224,000.
  • Per our database at Business Quant, Niagen Bioscience's Other Non-Current Assets tumbled by 73.75% in 2020 and then spiked by 142.11% in 2024.
  • Yearly analysis of 5 years shows Niagen Bioscience's Other Non-Current Assets stood at $200,000 in 2020, then fell by 24.00% to $152,000 in 2021, then remained steady at $152,000 in 2022, then remained steady at $152,000 in 2023, then surged by 142.11% to $368,000 in 2024.